Ignite Creation Date:
2025-12-25 @ 12:43 AM
Ignite Modification Date:
2026-03-01 @ 12:04 PM
Study NCT ID:
NCT03638167
Status:
COMPLETED
Last Update Posted:
2025-12-17
First Post:
2018-08-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS Tumors
Sponsor:
Seattle Children's Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
BrainChild-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None